Paula Lum

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California
    Paulo Telles Dias
    Núcleo de Estudos e Pesquisas em Atenção ao Uso de Drogas NEPAD Universidade do Estado do Rio de Janeiro State University of Rio de Janeiro, 20940 200 Rio de Janeiro, RJ, Brasil
    BMC Infect Dis 11:208. 2011
  2. doi request reprint Hepatitis B virus infection and immunization status in a new generation of injection drug users in San Francisco
    P J Lum
    Department of Medicine, University of California, San Francisco, CA, USA
    J Viral Hepat 15:229-36. 2008
  3. doi request reprint Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings
    Paula J Lum
    Department of Medicine, HIV AIDS Division, University of California, San Francisco, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 56:S91-7. 2011
  4. pmc Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study
    Paula J Lum
    Positive Health Program, Department of Medicine, University of California, San Francisco 94143 0874, USA
    Am J Public Health 93:919-23. 2003
  5. ncbi request reprint The medical management of opioid dependence in HIV primary care settings
    Paula J Lum
    Positive Health Program, Department of Medicine, University of California, San Francisco General Hospital, CA 94110, USA
    Curr HIV/AIDS Rep 3:195-204. 2006
  6. pmc Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection
    Kimberly Page
    University of California, San Francisco, San Francisco, CA 94105, USA
    Clin Infect Dis 56:405-13. 2013
  7. pmc Trends in methamphetamine use in young injection drug users in San Francisco from 1998 to 2004: the UFO Study
    Aline Inglez-Dias
    Department of Epidemiology and Biostatistics, University of California, San Francisco, CA 94105, USA
    Drug Alcohol Rev 27:286-91. 2008
  8. ncbi request reprint Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance
    Grant Nash Colfax
    AIDS Office, San Francisco Department of Public Health, San Francisco, California, USA
    AIDS 21:239-41. 2007
  9. ncbi request reprint Commercial sex work and risk of HIV infection among young drug-injecting men who have sex with men in San Francisco
    Oliver Bacon
    Center for AIDS Prevention Studies, Department of Medicine, University of California San Francisco, and the Positive Health Program, Department of Medicine, San Francisco General Hospital, California 94105, USA
    Sex Transm Dis 33:228-34. 2006
  10. ncbi request reprint Clinical presentation and course of acute hepatitis C infection in HIV-infected patients
    Annie Luetkemeyer
    HIV AIDS Division, San Francisco General Hospital, University of California at San Francisco, CA 94110, USA
    J Acquir Immune Defic Syndr 41:31-6. 2006

Research Grants

Detail Information

Publications20

  1. pmc Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California
    Paulo Telles Dias
    Núcleo de Estudos e Pesquisas em Atenção ao Uso de Drogas NEPAD Universidade do Estado do Rio de Janeiro State University of Rio de Janeiro, 20940 200 Rio de Janeiro, RJ, Brasil
    BMC Infect Dis 11:208. 2011
    ..In the United States (U.S.) HCV GT 1 is reported as the most common infecting GT among chronically infected patients. In Europe, however, recent studies have suggested that the epidemiology of HCV GTs is changing...
  2. doi request reprint Hepatitis B virus infection and immunization status in a new generation of injection drug users in San Francisco
    P J Lum
    Department of Medicine, University of California, San Francisco, CA, USA
    J Viral Hepat 15:229-36. 2008
    ..Until the broad effects of universal vaccination are seen, targeted and innovative approaches to immunizing young IDU in the US are needed to prevent a substantial number of new HBV infections...
  3. doi request reprint Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings
    Paula J Lum
    Department of Medicine, HIV AIDS Division, University of California, San Francisco, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 56:S91-7. 2011
    ..Pain syndromes are common in HIV-infected patients, who also are commonly affected by opioid-use disorders. Although opioids can treat pain, prescribers must consider the consequences of iatrogenic or missed addiction diagnoses...
  4. pmc Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study
    Paula J Lum
    Positive Health Program, Department of Medicine, University of California, San Francisco 94143 0874, USA
    Am J Public Health 93:919-23. 2003
  5. ncbi request reprint The medical management of opioid dependence in HIV primary care settings
    Paula J Lum
    Positive Health Program, Department of Medicine, University of California, San Francisco General Hospital, CA 94110, USA
    Curr HIV/AIDS Rep 3:195-204. 2006
    ..Buprenorphine, a partial opioid agonist approved for the office-based treatment of opioid dependence in 2002, may result in better health and substance use treatment outcomes for patients with HIV disease...
  6. pmc Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection
    Kimberly Page
    University of California, San Francisco, San Francisco, CA 94105, USA
    Clin Infect Dis 56:405-13. 2013
    ..Detection of hepatitis C virus (HCV) reinfection and intercalation (ie, intermittent recurrent bouts of viremia with homologous virus interspersed with aviremic periods) requires extensive and frequent evaluation and viral sequencing...
  7. pmc Trends in methamphetamine use in young injection drug users in San Francisco from 1998 to 2004: the UFO Study
    Aline Inglez-Dias
    Department of Epidemiology and Biostatistics, University of California, San Francisco, CA 94105, USA
    Drug Alcohol Rev 27:286-91. 2008
    ..To describe temporal trends in methamphetamine use among young injection drug users (IDU) in San Francisco...
  8. ncbi request reprint Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance
    Grant Nash Colfax
    AIDS Office, San Francisco Department of Public Health, San Francisco, California, USA
    AIDS 21:239-41. 2007
    ..We postulate that this association may be caused by methamphetamine-associated treatment interruptions among source partners...
  9. ncbi request reprint Commercial sex work and risk of HIV infection among young drug-injecting men who have sex with men in San Francisco
    Oliver Bacon
    Center for AIDS Prevention Studies, Department of Medicine, University of California San Francisco, and the Positive Health Program, Department of Medicine, San Francisco General Hospital, California 94105, USA
    Sex Transm Dis 33:228-34. 2006
    ..The objective of this study was to investigate the relationship between sex work and HIV infection among young injection drug-using men who have sex with men (MSM-IDU)...
  10. ncbi request reprint Clinical presentation and course of acute hepatitis C infection in HIV-infected patients
    Annie Luetkemeyer
    HIV AIDS Division, San Francisco General Hospital, University of California at San Francisco, CA 94110, USA
    J Acquir Immune Defic Syndr 41:31-6. 2006
    ..Unexplained transaminase elevations in HIV-infected patients, including men who have sex with men, should trigger an evaluation for acute HCV infection...
  11. pmc Hepatitis C virus risk behaviors within the partnerships of young injecting drug users
    Judith A Hahn
    Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA
    Addiction 105:1254-64. 2010
    ..We sought to determine whether perceiving one's injecting partner to be HCV positive was associated with decreased odds of engaging in receptive needle/syringe sharing (RNS) or ancillary equipment sharing (AES) with that partner...
  12. pmc Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study)
    Jennifer L Evans
    Prevention and Public Health Group, Department of Epidemiology and Biostatistics, University of California, San Francisco, 50 Beale St, Suite 1200, San Francisco, CA 94105, USA
    Drug Alcohol Depend 101:152-7. 2009
    ..Studies of injection drug use cessation have largely sampled adults in drug treatment settings. Little is known about injection cessation and relapse among young injection drug users (IDU) in the community...
  13. pmc Traveling young injection drug users at high risk for acquisition and transmission of viral infections
    Judith A Hahn
    Department of Medicine, University of California, San Francisco, CA 94143, USA
    Drug Alcohol Depend 93:43-50. 2008
    ..Young injection drug users (IDU) are highly mobile. It is not known how mobility affects their risk of acquiring and transmitting viral infections...
  14. ncbi request reprint Injection risk behavior among women syringe exchangers in San Francisco
    Paula J Lum
    The Positive Health Program, Department of Medicine, University of California, San Francisco, California 94143 0936, USA
    Subst Use Misuse 40:1681-96. 2005
    ..Additional efforts to reduce risky injection practices should focus on younger and homeless female IDU, as well as address selective risk taking between sexual partners...
  15. pmc Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study)
    Jennifer L Evans
    Department of Epidemiology and Biostatistics, University of California, San Francisco, CA 94105, USA
    J Urban Health 80:137-46. 2003
    ..Interventions to reduce sexual and injection practices that put women at risk of contracting hepatitis and HIV are needed...
  16. ncbi request reprint Hepatitis C virus seroconversion among young injection drug users: relationships and risks
    Judith A Hahn
    Department of Epidemiology, University of California, San Francisco, 94110, USA
    J Infect Dis 186:1558-64. 2002
    ..Interventions to reduce HCV transmission must recognize the importance of relationships on injecting risk...
  17. ncbi request reprint Prevalence and correlates of HIV infection among young injection drug users in San Francisco
    Kimberly Page Shafer
    Center for AIDS Prevention Studies, Department of Medicine, University of California at San Francisco, 94105, USA
    J Acquir Immune Defic Syndr 31:422-31. 2002
    ..We assessed the prevalence of HIV infection and associated risk behaviors among street-recruited young injection drug users (IDUs) in San Francisco...
  18. pmc Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection
    Kimberly Page
    Department of Epidemiology and Biostatistics, University of California, San Francisco, 50 Beale St, Ste 1200, San Francisco, CA 94105, USA
    J Infect Dis 200:1216-26. 2009
    ..Hepatitis C virus (HCV) infection, clearance, and reinfection are best studied in injection drug users (IDUs), who have the highest incidence of HCV and are likely to represent most infections...
  19. pmc Are young injection drug users ready and willing to participate in preventive HCV vaccine trials?
    Vivian Levy
    San Mateo County Health Systems, San Mateo, CA, USA
    Vaccine 28:5947-51. 2010
    ..Educational strategies will be needed to ensure understanding of key concepts prior to implementing HCV vaccine trials...
  20. ncbi request reprint Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough
    Kimberly Page-Shafer
    AIDS 21:1967-9. 2007

Research Grants5

  1. A Randomized Trial of Vaccine Adherence in Young IDU
    Paula Lum; Fiscal Year: 2006
    ..abstract_text> ..